Prioritizing quantum computing use cases in the drug discovery and development pipeline
Other text in scientific journal, 2025
drug discovery and development
quantum computing
quantum chemistry
molecular interactions
Author
Arseny Kovyrshin
Chalmers, Chemistry and Chemical Engineering
AstraZeneca AB
Lars Tornberg
AstraZeneca AB
Jason Crain
University of Oxford
IBM Research
Stefano Mensa
STFC Hartree Centre
Ivano Tavernelli
IBM Research
Anders Broo
AstraZeneca AB
Drug Discovery Today
1359-6446 (ISSN) 18785832 (eISSN)
Vol. 30 3 104323Wallenberg Centre for Quantum Technology (WACQT)
Knut and Alice Wallenberg Foundation (KAW 2017.0449, KAW2021.0009, KAW2022.0006), 2018-01-01 -- 2030-03-31.
Subject Categories (SSIF 2025)
Computer Sciences
DOI
10.1016/j.drudis.2025.104323